EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nuclear Magnetic Resonance ‐based fragment screen of the E3 ligase Fem‐1 homolog B

Jade M Katinas iD, Kangsa Amporndanai, Ashley J Taylor, Kristie L Rose, Peter C Gareiss, Roberto A Crespo, Jason Phan, Alex G Waterson, Stephen W Fesik

Protein Science · 2025-12 · 34 (12)

DOI: 10.1002/pro.70365 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Protein Science, online erschienen am 13.11.2025. Verfasst von Jade M Katinas und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee, USA. Hauptthemen laut MEDLINE: Ubiquitin-Protein Ligases, Carrier Proteins, Cell Cycle Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, Arvinas, Inc, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeted protein degradation using PROTACs (PROteolysis TArgeting Chimeras) has emerged as a transformative therapeutic strategy, largely relying on a small number of E3 ubiquitin ligases such as CRBN and VHL. However, resistance, toxicity, and poor oral bioavailability limit the utility of PROTACs and highlight the need to expand the E3 ligase toolbox. Fem‐1 homolog B (FEM1B) is a lesser‐known E3 ligase that offers a promising alternative due to its broad expression and ability to recognize diverse degron motifs. Here, we describe the development of a stable construct of FEM1B, the results of a protein‐observed NMR‐based fragment screen using this construct, and the X‐ray structures of some of the fragment hits when bound to the protein. From these results, new PROTACs utilizing FEM1B as the E3 ligase may be discovered, providing an alternative E3 ligase for targeted protein degradation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ubiquitin-Protein LigasesCarrier ProteinsCell Cycle ProteinsHumansProteolysisNuclear Magnetic Resonance, BiomolecularCrystallography, X-RayModels, Molecular

Stichwörter der Autor:innen

1H‐13C‐SOFAST HMQCE3 ligaseFem‐1 homolog B (FEM1B)NMRX‐ray crystal structureconstruct designfragment screen

Substanzen

Ubiquitin-Protein LigasesCarrier ProteinsCell Cycle Proteins

Autor:innen und Institutionen

  • Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
  • Arvinas, Inc., New Haven, Connecticut, USA.
  • Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
  • Department of Chemistry, Vanderbilt University, Nashville, Tennessee, USA.

ORCID-Profile: Jade M Katinas

Förderung

  • NIH HHS
  • Arvinas, Inc
  • NIGMS NIH HHS
  • NCRR NIH HHS

Zitieren

APA

Katinas, J. M., Amporndanai, K., Taylor, A. J., Rose, K. L., Gareiss, P. C., Crespo, R. A., Phan, J., Waterson, A. G., & Fesik, S. W. (2025). Nuclear Magnetic Resonance ‐based fragment screen of the E3 ligase Fem‐1 homolog B. Protein Science, 34(12). https://doi.org/10.1002/pro.70365

Vancouver

Katinas JM, Amporndanai K, Taylor AJ, Rose KL, Gareiss PC, Crespo RA, et al. Nuclear Magnetic Resonance ‐based fragment screen of the E3 ligase Fem‐1 homolog B. Protein Science. 2025;34(12). doi:10.1002/pro.70365

BibTeX
@article{Katinas2025,
  author = {Katinas, Jade M and Amporndanai, Kangsa and Taylor, Ashley J and Rose, Kristie L and Gareiss, Peter C and Crespo, Roberto A and Phan, Jason and Waterson, Alex G and Fesik, Stephen W},
  title = {Nuclear Magnetic Resonance ‐based fragment screen of the E3 ligase Fem‐1 homolog B},
  journal = {Protein Science},
  year = {2025},
  volume = {34},
  number = {12},
  doi = {10.1002/pro.70365}
}
Kostenlos starten →